Global Biotechnology Market Report and Forecast 2024-2032

Competitive Landscape

The key features of the market report include patent analysis, clinical trial analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the biotechnology market are as follows:

Abbott

This American multinational medical devices and healthcare company has a robust market presence and is actively engaged in strategic acquisition initiatives to drive innovation and expand market reach. The company significantly invests in developing innovative molecular testing technologies. It is known for its oncology diagnostics, infectious disease products, and laboratory solutions in the biotechnology industry.

Agilent Technologies Inc.

California-based Agilent Technologies Inc. is a leading provider of analytical laboratory technologies, reagents, and consumables for laboratory processes. In April 2024 , the company entered into a collaboration with the University of California San Diego (UC San Diego) to establish the Agilent Centre of Excellence (CoE) in Cellular Intelligence for advancing research on editing and engineering cells to treat diseases and expedite the development of novel bioproducts. Additionally, the company is integrating the latest technologies such as automated workflow solutions in its product lines to exert dominance in the biotechnology instruments market.

Danaher

Headquartered in Washington, D.C., this global science and technology is known for its launch of cutting-edge diagnostic and analytical instruments and has been engaged in mergers and acquisitions to reinforce its presence in the market. Danaher is increasingly focusing on the development of genomic medicine and has established many strategic collaborations with leading academic researchers in recent years including a major new center with Jennifer Doudna (Nobel laureate) and the Innovative Genomics Institute (IGI)  to manufacture advanced therapies and fuel the adoption of gene-edited cell therapies.

BD

American multinational medical technology Becton, Dickinson and Company (BD) is a key player in the biotechnology market. The company provides instruments and reagents for research and clinical applications, including flow cytometry, cell analysis, and laboratory automation. BD is focused on expanding its global footprint into new markets and also strengthens its presence in established markets by collaborating and investing in other healthcare companies. For instance, it offered funding support to Day Zero Diagnostics to accelerate the development of sequencing-based infectious disease diagnostics.

Other players in the market include Bio-Rad Laboratories Inc., General Electric, bioMérieux SA, LONZA, F. Hoffmann-La Roche Ltd., Hoefer, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, and Olympus Corporation, among others.

The competitive landscape is characterized by rising investments in technological innovations such as artificial intelligence and machine learning, strategic mergers, and acquisitions, and a growing focus on expanding into new markets and therapeutic areas.

Biotechnology Market Report Snapshots

Biotechnology Market Size

Biotechnology Market Growth

Biotechnology Market Trends

Biotechnology Market Share

Biotechnology Market Regional Analysis

Biotechnology Companies